symbol,statement_type,period_end,line_item,value
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,15920872.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,15920872.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,1486616000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,1504132000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,615915000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,2278291000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,153717000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,615915000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,774159000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,1088293000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,774044000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,-115000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,774159000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,614950000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,159209000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,159209000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,2582859000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,387856000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,0.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,314134000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,314134000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,56446000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,2195003000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,69266000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,1189998000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,1189998000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,11671000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Payables,816858000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,0.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,816858000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,3356903000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,1008183000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,36774000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,4098000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,71304000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,71304000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,158244000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,119975000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,38269000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,737763000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,737763000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,27858000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,709905000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Properties,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,2348720000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,254893000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventory,1030222000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,11328000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,9884000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,924435000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,117958000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,100442000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,17516000.0
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
BALPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,15804372.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,15804372.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,1354033000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,1422504000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,540844000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,2088934000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,311043000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,540844000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,26514000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,692944000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,1056438000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,692615000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,-329000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,692944000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,6657000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,193419000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,312875000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,158044000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,158044000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,2502640000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,472216000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,-1000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,50860000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,4511000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,39610000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,377236000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,13742000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,363494000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,50860000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,2030424000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,47596000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,1045268000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,12772000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,1032496000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,9487000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,9487000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Payables,808742000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,10724000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,1199000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,22176000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,774643000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,3195255000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,853788000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,1710000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,27669000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,24121000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,2809000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,2809000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,0.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,152100000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,113814000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,38286000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,642545000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-458599000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,1101144000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,26493000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,616051000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,643868000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,281855000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,148928000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,2341467000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,3304000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,9467000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,208486000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventory,878115000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,54902000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,263785000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,309165000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,250263000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,46587000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,1167000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,996218000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-16550000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,1012768000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,199290000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,157333000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,41957000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,9245000.0
BALPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,32712000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,15689872.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,15689872.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,1295122000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,1330792000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,495035000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,1947884000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,188215000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,495035000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,20799000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,637891000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,943122000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,637022000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,-869000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,637891000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,13926000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,146886000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,301839000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,156899000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,156899000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,2494701000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,401357000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,-1000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,50675000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,4511000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,28691000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,317481000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,12250000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,305231000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,50675000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,2093344000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,53770000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,1013311000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,8549000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,1004762000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,6396000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,6396000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Payables,860752000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,9975000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,1493000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,60055000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,789229000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,3131723000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,850164000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,2422000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,25430000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,21666000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,13978000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,13978000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,0.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,142856000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,104570000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,38286000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,641992000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-391635000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,1033627000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,20199000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,621792000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,613077000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,251423000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,148928000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,2281559000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,2532000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,14162000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,233169000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventory,980050000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,53634000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,287451000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,274849000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,364116000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,37260000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,1453000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,939759000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-14620000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,954379000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,74627000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,59756000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,14871000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,6192000.0
BALPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,8679000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,15572372.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,15572372.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,1025280000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,1066564000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,468070000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,1622676000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,189256000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,468070000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,30156000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,586268000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,856403000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,584924000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,-1344000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,586268000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,18503000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,135813000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,266766000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,148224000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,148224000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,2020403000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,363956000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,-3000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,46941000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,18302000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,6044000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,292672000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,22537000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,270135000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,46941000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,1656447000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,34878000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,773892000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,7619000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,766273000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,7279000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,7279000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Payables,750129000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,48828000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,1736000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,43926000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,655639000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,2605327000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,759624000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,-1000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,10762000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,18090000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,18090000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,0.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,118198000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,79912000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,38286000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,611179000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-346855000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,958034000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,55449000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,555730000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,558052000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,265430000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,79103000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,1845703000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,3101000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,13699000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,195327000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventory,743956000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,48808000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,199144000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,184442000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,311562000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,75652000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,992000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,753123000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-9134000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,762257000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,60845000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,49717000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,11128000.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,0.0
BALPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,11128000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,19232000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,94520000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,266766000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,-2000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,40654000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,19491000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,16152000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,3080000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,6561000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Payables,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,37813000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,1852000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,10796000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,0.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-286424000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,539089000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,243319000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,79103000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,11911000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,256432000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,41618000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,214233000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,120408000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,227594000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-7546000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,679516000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,201000.0
BALPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,10033000.0
